Current Knowledge about Gastric Microbiota with Special Emphasis on Helicobacter pylori-Related Gastric Conditions
Abstract
:1. Introduction
2. Gastric Microbiota Composition in Health and Disease
3. H.p.-Mediated Gastric Inflammation
4. H.p. and Non-H.p. Organism-Mediated Gastric Tumorigenesis
5. The Relationship between Gastric Innate Lymphoid Cells and H.p.
6. Use of Natural Products to Treat H.p. Infection
6.1. Effects of Probiotics and Prebiotics on the Gastric Microbiota
6.2. Effects of Polyphenols on the Gastric Microbiota
7. Conclusions
Author Contributions
Funding
Data Availability Statement
Conflicts of Interest
Abbreviations
Cag A | Cytotoxin-associated gene A |
COX | cyclooxygenase |
EBV | Epstein–Barr Virus |
FMT | Fecal microbial transplantation |
FOS | Fructooligosaccharides |
H.p. | Helicobacter pylori |
IFN | Interferon |
IL | Interleukin |
ILCs | Innate lymphoid cells |
LPS | Lipopolysaccharides |
MD-2 | Myeloid differentiation factor-2 |
NCR | Natural cytotoxic receptor |
NK | Natural killer |
PG | Prostaglandin |
SQT | Standard quadruple therapy |
T4SS | Type IV secretion system |
Th | T helper |
TLRs | Toll-like receptors |
Vac A | vacuolar toxin A |
References
- Yamaoka, Y.; Saruuljavkhlan, B.; Alfaray, R.I.; Linz, B. Pathogenomics of Helicobacter pylori. Curr. Top. Microbiol. Immunol. 2023, 444, 117–155. [Google Scholar] [CrossRef]
- Kronsteiner, B.; Bassaganya-Riera, J.; Philipson, C.; Viladomiu, M.; Carbo, A.; Abedi, V.; Hontecillas, R. Systems-wide analyses of mucosal immune responses to Helicobacter pylori at the interface between pathogenicity and symbiosis. Gut Microbes 2016, 7, 3–21. [Google Scholar] [CrossRef]
- Fiorani, M.; Tohumcu, E.; Del Vecchio, L.E.; Porcari, S.; Cammarota, G.; Gasbarrini, A.; Ianiro, G. The Influence of Helicobacter pylori on Human Gastric and Gut Microbiota. Antibiotics 2023, 12, 765. [Google Scholar] [CrossRef]
- Wang, F.; Meng, W.; Wang, B.; Qiao, L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 2014, 345, 196–202. [Google Scholar] [CrossRef]
- Beccaceci, G.; Sigal, M. Unwelcome guests—The role of gland-associated Helicobacter pylori infection in gastric carcinogenesis. Front. Oncol. 2023, 13, 1171003. [Google Scholar] [CrossRef]
- Bhattacharjee, A.; Sahoo, O.S.; Sarkar, A.; Bhattacharya, S.; Chowdhury, R.; Kar, S.; Mukherjee, O. Infiltration to infection: Key virulence players of Helicobacter pylori pathogenicity. Infection 2024, 52, 345–384. [Google Scholar] [CrossRef]
- Wang, Y.; Han, W.; Wang, N.; Han, M.; Ban, M.; Dai, J.; Dong, Y.; Sun, T.; Xu, J. The role of microbiota in the development and treatment of gastric cancer. Front. Oncol. 2023, 13, 1224669. [Google Scholar] [CrossRef]
- Ndegwa, N.; Ploner, A.; Andersson, A.F.; Zagai, U.; Andreasson, A.; Vieth, M.; Talley, N.J.; Agreus, L.; Ye, W. Gastric Microbiota in a Low-Helicobacter pylori Prevalence General Population and Their Associations with Gastric Lesions. Clin. Transl. Gastroenterol. 2020, 11, e00191. [Google Scholar] [CrossRef]
- Brandi, G.; Biavati, B.; Calabrese, C.; Granata, M.; Nannetti, A.; Mattarelli, P.; Di Febo, G.; Saccoccio, G.; Biasco, G. Urease-positive bacteria other than Helicobacter pylori in human gastric juice and mucosa. Am. J. Gastroenterol. 2006, 101, 1756–1761. [Google Scholar] [CrossRef]
- Pereira-Marques, J.; Ferreira, R.M.; Pinto-Ribeiro, I.; Figueiredo, C. Helicobacter pylori Infection, the Gastric Microbiome and Gastric Cancer. Adv. Exp. Med. Biol. 2019, 1149, 195–210. [Google Scholar] [CrossRef] [PubMed]
- Zhu, X.; Zhao, Y.; Sun, N.; Li, C.; Jiang, Q.; Zhang, Y.; Wei, H.; Li, Y.; Hu, Q.; Li, X. Comparison of the gut microbiota and untargeted gut tissue metabolome of Chinese mitten crabs (Eriocheir sinensis) with different shell colors. Front. Microbiol. 2023, 14, 1218152. [Google Scholar] [CrossRef] [PubMed]
- Elghannam, M.T.; Hassanien, M.H.; Ameen, Y.A.; Turky, E.A.; ELattar, G.M.; ELRay, A.A.; ELTalkawy, M.D. Helicobacter pylori and oral-gut microbiome: Clinical implications. Infection 2024, 52, 289–300. [Google Scholar] [CrossRef] [PubMed]
- Chen, Y.C.; Malfertheiner, P.; Yu, H.T.; Kuo, C.L.; Chang, Y.Y.; Meng, F.T.; Wu, Y.X.; Hsiao, J.L.; Chen, M.J.; Lin, K.P.; et al. Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer between 1980 and 2022. Gastroenterology 2024, 166, 605–619. [Google Scholar] [CrossRef] [PubMed]
- Ballini, A.; Charitos, I.A.; Cantore, S.; Topi, S.; Bottalico, L.; Santacroce, L. About Functional Foods: The Probiotics and Prebiotics State of Art. Antibiotics 2023, 12, 635. [Google Scholar] [CrossRef] [PubMed]
- Swanson, K.S.; Gibson, G.R.; Hutkins, R.; Reimer, R.A.; Reid, G.; Verbeke, K.; Scott, K.P.; Holscher, H.D.; Azad, M.B.; Delzenne, N.M.; et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat. Rev. Gastroenterol. Hepatol. 2020, 17, 687–701. [Google Scholar] [CrossRef] [PubMed]
- Arrigoni, R.; Ballini, A.; Santacroce, L.; Cantore, S.; Inchingolo, A.; Inchingolo, F.; Di Domenico, M.; Quagliuolo, L.; Boccellino, M. Another Look at Dietary Polyphenols: Challenges in Cancer Prevention and Treatment. Curr. Med. Chem. 2022, 9, 1061–1082. [Google Scholar] [CrossRef] [PubMed]
- Rosales, T.K.O.; Fabi, J.P. Valorization of polyphenolic compounds from food industry by-products for application in polysaccharide-based nanoparticles. Front. Nutr. 2023, 10, 1144677. [Google Scholar] [CrossRef]
- Li, M.; Zheng, Y.; Zhao, J.; Liu, M.; Shu, X.; Li, Q.; Wang, Y.; Zhou, Y. Polyphenol Mechanisms against Gastric Cancer and Their Interactions with Gut Microbiota: A Review. Curr. Oncol. 2022, 29, 5247–5261. [Google Scholar] [CrossRef]
- Colella, M.; Charitos, I.A.; Ballini, A.; Cafiero, C.; Topi, S.; Palmirotta, R.; Santacroce, L. Microbiota revolution: How gut microbes regulate our lives. World J. Gastroenterol. 2023, 29, 4368–4383. [Google Scholar] [CrossRef]
- Barra, W.F.; Sarquis, D.P.; Khayat, A.S.; Khayat, B.C.M.; Demachki, S.; Anaissi, A.K.M.; Ishak, G.; Santos, N.P.C.; dos Santos, S.E.B.; Burbano, R.R.; et al. Gastric Cancer Microbiome. Pathobiology 2021, 88, 156–169. [Google Scholar] [CrossRef]
- Marshall, B.J.; Warren, J.R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984, 1, 1311–1315. [Google Scholar] [CrossRef] [PubMed]
- Bik, E.M.; Eckburg, P.B.; Gill, S.R.; Nelson, K.E.; Purdom, E.A.; Francois, F.; Perez-Perez, G.; Blaser, M.J.; Relman, D.A. Molecular analysis of the bacterial microbiota in the human stomach. Proc. Natl. Acad. Sci. USA 2006, 103, 732–737. [Google Scholar] [CrossRef] [PubMed]
- Delgado, S.; Cabrera-Rubio, R.; Mira, A.; Suárez, A.; Mayo, B. Microbiological survey of the human gastric ecosystem using culturing and pyrosequencing methods. Microb. Ecol. 2013, 65, 763–772. [Google Scholar] [CrossRef] [PubMed]
- den Hollander, W.J.; Holster, I.L.; den Hoed, C.M.; Capelle, L.G.; Tang, T.J.; Anten, M.-P.; Prytz-Berset, I.; Witteman, E.M.; ter Borg, F.; Hartog, G.D.; et al. Surveillance of premalignant gastric lesions: A multicentre prospective cohort study from low incidence regions. Gut 2019, 68, 585–593. [Google Scholar] [CrossRef] [PubMed]
- Sung, J.; Kim, N.; Kim, J.; Jo, H.J.; Park, J.H.; Nam, R.H.; Seok, Y.J.; Kim, Y.R.; Lee, D.H.; Jung, H.C. Comparison of Gastric Microbiota between Gastric Juice and Mucosa by Next Generation Sequencing Method. J. Cancer Prev. 2016, 21, 60–65. [Google Scholar] [CrossRef]
- Espinoza, J.L.; Matsumoto, A.; Tanaka, H.; Matsumura, I. Gastric microbiota: An emerging player in Helicobacter pylori-induced gastric malignancies. Cancer Lett. 2018, 414, 147–152. [Google Scholar] [CrossRef] [PubMed]
- Toh, J.W.T.; Wilson, R.B. Pathways of Gastric Carcinogenesis, Helicobacter pylori Virulence and Interactions with Antioxidant Systems, Vitamin C and Phytochemicals. Int. J. Mol. Sci. 2020, 21, 6451. [Google Scholar] [CrossRef]
- Topi, S.; Santacroce, L.; Bottalico, L.; Ballini, A.; Inchingolo, A.D.; Dipalma, G.; Charitos, I.A.; Inchingolo, F. Gastric Cancer in History: A Perspective Interdisciplinary Study. Cancers 2020, 12, 264. [Google Scholar] [CrossRef] [PubMed]
- Reed, P.I. Vitamin C Helicobacter pylori infection and gastric carcinogenesis. Int. J. Vitam. Nutr. Res. 1999, 69, 220–227. [Google Scholar] [CrossRef]
- de Brito, B.B.; da Silva, F.A.F.; Soares, A.S.; Pereira, V.A.; Santos, M.L.C.; Sampaio, M.M.; Neves, P.H.M.; de Melo, F.F. Pathogenesis and clinical management of Helicobacter pylori gastric infection. World J. Gastroenterol. 2019, 25, 5578–5589. [Google Scholar] [CrossRef]
- Mahdavi, J.; Sondén, B.; Hurtig, M.; Olfat, F.O.; Forsberg, L.; Roche, N.; Angstrom, J.; Larsson, T.; Teneberg, S.; Karlsson, K.A.; et al. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 2002, 297, 573–578. [Google Scholar] [CrossRef]
- Chen, C.C.; Liou, J.M.; Lee, Y.C.; Hong, T.C.; El-Omar, E.M.; Wu, M.S. The interplay between Helicobacter pylori and gastrointestinal microbiota. Gut Microbes 2021, 13, 1909459. [Google Scholar] [CrossRef]
- Goldstone, A.R.; Quirke, P.; Dixon, M.F. Helicobacter pylori infection and gastric cancer. J. Pathol. 1996, 179, 129–137. [Google Scholar] [CrossRef]
- Santacroce, L.; Passarelli, P.C.; Azzolino, D.; Bottalico, L.; Charitos, I.A.; Cazzolla, A.P.; Colella, M.; Topi, S.; Godoy, F.G.; D’Addona, A. Oral microbiota in human health and disease: A perspective. Exp. Biol. Med. 2023, 248, 1288–1301. [Google Scholar] [CrossRef] [PubMed]
- Aviles-Jimenez, F.; Vazquez-Jimenez, F.; Medrano-Guzman, R.; Mantilla, A.; Torres, J. Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer. Sci. Rep. 2014, 4, 4202. [Google Scholar] [CrossRef] [PubMed]
- Eun, C.S.; Kim, B.K.; Han, D.S.; Kim, S.Y.; Kim, K.M.; Choi, B.Y.; Song, K.S.; Kim, Y.S.; Kim, J.F. Differences in gastric mucosal microbiota profiling in patients with chronic gastritis, intestinal metaplasia, and gastric cancer using pyrosequencing methods. Helicobacter 2014, 19, 407–416. [Google Scholar] [CrossRef]
- Hu, Y.L.; Pang, W.; Huang, Y.; Zhang, Y.; Zhang, C.J. The Gastric Microbiome Is Perturbed in Advanced Gastric Adenocarcinoma Identified through Shotgun Metagenomics. Front. Cell Infect. Microbiol. 2018, 12, 433. [Google Scholar] [CrossRef]
- Dai, D.; Yang, Y.; Yu, J.; Dang, T.; Qin, W.; Teng, L.; Ye, J.; Jiang, H. Interactions between gastric microbiota and metabolites in gastric cancer. Cell Death Dis. 2021, 12, 1104. [Google Scholar] [CrossRef] [PubMed]
- Liu, X.; Liu, L.; Ji, Y.; Li, C.; Wei, T.; Yang, X.; Zhang, Y.; Cai, X.; Gao, Y.; Xu, W.; et al. Enrichment of short mutant cell-free DNA fragments enhanced detection of pancreatic cancer. eBioMedicine 2019, 41, 345–356. [Google Scholar] [CrossRef]
- Maldonado-Contreras, A.; Goldfarb, K.C.; Godoy-Vitorino, F.; Karaoz, U.; Contreras, M.; Blaser, M.J.; Brodie, E.L.; Dominguez-Bello, M.G. Structure of the human gastric bacterial community in relation to Helicobacter pylori status. ISME J. 2011, 5, 574–579. [Google Scholar] [CrossRef]
- Yin, Y.N.; Wang, C.L.; Liu, X.W.; Cui, Y.; Xie, N.; Yu, Q.-F.; Li, F.-J.; Lu, F.-G. Gastric and duodenum microflora analysis after long-term Helicobacter pylori infection in Mongolian Gerbils. Helicobacter 2011, 16, 389–397. [Google Scholar] [CrossRef] [PubMed]
- Iino, C.; Shimoyama, T.; Chinda, D.; Arai, T.; Chiba, D.; Nakaji, S.; Fukuda, S. Infection of Helicobacter pylori and Atrophic Gastritis Influence Lactobacillus in Gut Microbiota in a Japanese Population. Front. Immunol. 2018, 9, 712. [Google Scholar] [CrossRef]
- Elbehiry, A.; Marzouk, E.; Aldubaib, M.; Abalkhail, A.; Anagreyyah, S.; Anajirih, N.; Almuzaini, A.M.; Rawway, M.; Alfadhel, A.; Draz, A.; et al. Helicobacter pylori Infection: Current Status and Future Prospects on Diagnostic, Therapeutic and Control Challenges. Antibiotics 2023, 12, 191. [Google Scholar] [CrossRef] [PubMed]
- Alvarez-Arellano, L.; Cortés-Reynosa, P.; Sánchez-Zauco, N.; Salazar, E.; Torres, J.; Maldonado-Bernal, C. TLR9 and NF-κB are partially involved in activation of human neutrophils by Helicobacter pylori and its purified DNA. PLoS ONE 2014, 9, e101342. [Google Scholar] [CrossRef]
- Lembo, A.; Caradonna, L.; Magrone, T.; Mastronardi, M.L.; Caccavo, D.; Jirillo, E.; Amati, L. Helicobacter pylori organisms induce expression of activation and apoptotic surface markers on human lymphocytes and AGS cells: A cytofluorimetric evaluation. Immunopharmacol. Immunotoxicol. 2002, 24, 567–582. [Google Scholar] [CrossRef] [PubMed]
- Ansari, S.; Yamaoka, Y. Role of vacuolating cytotoxin A in Helicobacter pylori infection and its impact on gastric pathogenesis. Expert Rev. Anti Infect. Ther. 2020, 18, 987–996. [Google Scholar] [CrossRef]
- Liu, X.; He, B.; Cho, W.C.; Pan, Y.; Chen, J.; Ying, H.; Wang, F.; Lin, K.; Peng, H.; Wang, S. A systematic review on the association between the Helicobacter pylori vacA i genotype and gastric disease. FEBS Open Bio 2016, 6, 409–417. [Google Scholar] [CrossRef]
- Kaneko, K.; Zaitoun, A.M.; Letley, D.P.; Rhead, J.L.; Torres, J.; Spendlove, I.; Atherton, J.C.; Robinson, K. The active form of Helicobacter pylori vacuolating cytotoxin induces decay-accelerating factor CD55 in association with intestinal metaplasia in the human gastric mucosa. J. Pathol. 2022, 258, 199–209. [Google Scholar] [CrossRef]
- Krakowiak, M.S.; Noto, J.M.; Piazuelo, M.B.; Hardbower, D.M.; Romero-Gallo, J.; Delgado, A.; Chaturvedi, R.; Correa, P.; Wilson, K.T.; Peek, R.M., Jr. Matrix metalloproteinase 7 restrains Helicobacter pylori-induced gastric inflammation and premalignant lesions in the stomach by altering macrophage polarization. Oncogene 2015, 34, 1865–1871. [Google Scholar] [CrossRef]
- Russo, F.; Jirillo, E.; Clemente, C.; Messa, C.; Chiloiro, M.; Riezzo, G.; Amati, L.; Caradonna, L.; Di Leo, A. Circulating cytokines and gastrin levels in asymptomatic subjects infected by Helicobacter pylori (H. pylori). Immunopharmacol. Immunotoxicol. 2001, 23, 13–24. [Google Scholar] [CrossRef]
- Sokolova, O.; Naumann, M. Crosstalk between DNA Damage and Inflammation in the Multiple Steps of Gastric Carcinogenesis. Curr. Top. Microbiol. Immunol. 2019, 421, 107–137. [Google Scholar] [CrossRef] [PubMed]
- Oshima, H.; Hioki, K.; Popivanova, B.K.; Oguma, K.; Van Rooijen, N.; Ishikawa, T.; Oshima, M. Prostaglandin E2 signaling and bacterial infection recruit tumor-promoting macrophages to mouse gastric tumors. Gastroenterology 2011, 140, 596–607.e7. [Google Scholar] [CrossRef] [PubMed]
- Wong, B.C.; Zhang, L.; Ma, J.L.; Pan, K.F.; Li, J.Y.; Shen, L.; Liu, W.D.; Feng, G.S.; Zhang, X.D.; Li, J.; et al. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions. Gut 2012, 61, 812–818. [Google Scholar] [CrossRef] [PubMed]
- Chang, Y.J.; Wu, M.S.; Lin, J.T.; Sheu, B.S.; Muta, T.; Inoue, H.; Chen, C.C. Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-kappaB activation. Mol. Pharmacol. 2004, 66, 1465–1477. [Google Scholar] [CrossRef] [PubMed]
- Lim, J.W.; Kim, H.; Kim, K.H. Nuclear factor-kappaB regulates cyclooxygenase-2 expression and cell proliferation in human gastric cancer cells. Lab. Investig. 2001, 81, 349–360. [Google Scholar] [CrossRef] [PubMed]
- Takehara, H.; Iwamoto, J.; Mizokami, Y.; Takahashi, K.; Ootubo, T.; Miura, S.; Narasaka, T.; Takeyama, H.; Omata, T.; Shimokobe, K.; et al. Involvement of cyclooxygenase-2-prostaglandin E2 pathway in interleukin-8 production in gastric cancer cells. Dig. Dis. Sci. 2006, 51, 2188–2197, Erratum in Dig. Dis. Sci. 2012, 57, 261. [Google Scholar] [CrossRef] [PubMed]
- Blaser, N.; Backert, S.; Pachathundikandi, S.K. Immune Cell Signaling by Helicobacter pylori: Impact on Gastric Pathology. Adv. Exp. Med. Biol. 2019, 1149, 77–106. [Google Scholar] [CrossRef] [PubMed]
- Lagunes-Servin, H.; Torres, J.; Maldonado-Bernal, C.; Pérez-Rodríguez, M.; Huerta-Yépez, S.; de la Garza, A.M.; Muñoz-Pérez, L.; Flores-Luna, L.; Ramón-García, G.; Camorlinga-Ponce, M. Toll-like receptors and cytokines are upregulated during Helicobacter pylori infection in children. Helicobacter 2013, 18, 423–432. [Google Scholar] [CrossRef] [PubMed]
- Pachathundikandi, S.K.; Tegtmeyer, N.; Arnold, I.C.; Lind, J.; Neddermann, M.; Falkeis-Veits, C.; Chattopadhyay, S.; Brönstrup, M.; Tegge, W.; Hong, M.; et al. T4SS-dependent TLR5 activation by Helicobacter pylori infection. Nat. Commun. 2019, 10, 5717. [Google Scholar] [CrossRef]
- Săsăran, M.O.; Meliț, L.E.; Dobru, E.D. MicroRNA Modulation of Host Immune Response and Inflammation Triggered by Helicobacter pylori. Int. J. Mol. Sci. 2021, 22, 1406. [Google Scholar] [CrossRef]
- Pandiyan, P.; Bhaskaran, N.; Zou, M.; Schneider, E.; Jayaraman, S.; Huehn, J. Microbiome Dependent Regulation of Tregs and Th17 Cells in Mucosa. Front. Immunol. 2019, 10, 426. [Google Scholar] [CrossRef]
- Magrone, T.; Jirillo, E. The Tolerant Immune System: Biological Significance and Clinical Implications of T Cell Tolerance. Endocr. Metab. Immune Disord. Drug Targets 2019, 19, 580–593. [Google Scholar] [CrossRef] [PubMed]
- Ding, L.; Chakrabarti, J.; Sheriff, S.; Li, Q.; Hong, H.N.T.; Sontz, R.A.; Mendoza, Z.E.; Schreibeis, A.; Helmrath, M.A.; Zavros, Y.; et al. Toll-like Receptor 9 Pathway Mediates Schlafen+-MDSC Polarization during Helicobacter-induced Gastric Metaplasias. Gastroenterology 2022, 163, 411–425.e4. [Google Scholar] [CrossRef]
- Hynes, S.O.; Ferris, J.A.; Szponar, B.; Wadström, T.; Fox, J.G.; O’Rourke, J.; Larsson, L.; Yaquian, E.; Ljungh, A.; Clyne, M.; et al. Comparative chemical and biological characterization of the lipopolysaccharides of gastric and enterohepatic helicobacters. Helicobacter 2004, 9, 313–323. [Google Scholar] [CrossRef]
- Lembo, A.; Caradonna, L.; Magrone, T.; Mastronardi, M.; Caccavo, D.; Jirillo, E.; Amati, L. Helicobacter pylori infection, immune response and vaccination. Curr. Drug Targets Immune Endocr. Metabol. Disord. 2001, 1, 199–208. [Google Scholar] [CrossRef]
- Di Leo, A.; Messa, C.; Russo, F.; Linsalata, M.; Amati, L.; Caradonna, L.; Pece, S.; Pellegrino, N.M.; Caccavo, D.; Antonaci, S.; et al. Helicobacter pylori infection and host cell responses. Immunopharmacol. Immunotoxicol. 1999, 21, 803–846. [Google Scholar] [CrossRef]
- Smith, M.F., Jr.; Mitchell, A.; Li, G.; Ding, S.; Fitzmaurice, A.M.; Ryan, K.; Crowe, S.; Goldberg, J.B. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J. Biol. Chem. 2003, 278, 32552–32560. [Google Scholar] [CrossRef] [PubMed]
- Toshchakov, V.; Jones, B.W.; Lentschat, A.; Silva, A.; Perera, P.-Y.; Thomas, K.; Cody, M.J.; Zhang, S.; Williams, B.R.G.; Major, J.; et al. TLR2 and TLR4 agonists stimulate unique repertoires of host resistance genes in murine macrophages: Interferon-beta-dependent signaling in TLR4-mediated responses. J. Endotoxin Res. 2003, 9, 169–175. [Google Scholar] [CrossRef] [PubMed]
- Kawahara, T.; Teshima, S.; Oka, A.; Sugiyama, T.; Kishi, K.; Rokutan, K. Type I Helicobacter pylori lipopolysaccharide stimulates toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells. Infect. Immun. 2001, 69, 4382–4389. [Google Scholar] [CrossRef]
- Nagai, Y.; Akashi, S.; Nagafuku, M.; Ogata, M.; Iwakura, Y.; Akira, S.; Kitamura, T.; Kosugi, A.; Kimoto, M.; Miyake, K. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 2002, 3, 667–672. [Google Scholar] [CrossRef]
- Li, N.; Xu, H.; Ou, Y.; Feng, Z.; Zhang, Q.; Zhu, Q.; Cai, Z. LPS-induced CXCR7 expression promotes gastric Cancer proliferation and migration via the TLR4/MD-2 pathway. Diagn. Pathol. 2019, 14, 3. [Google Scholar] [CrossRef] [PubMed]
- Ito, N.; Tsujimoto, H.; Ueno, H.; Xie, Q.; Shinomiya, N. Helicobacter pylori-Mediated Immunity and Signaling Transduction in Gastric Cancer. J. Clin. Med. 2020, 9, 3699. [Google Scholar] [CrossRef] [PubMed]
- Sijmons, D.; Guy, A.J.; Walduck, A.K.; Ramsland, P.A. Helicobacter pylori and the Role of Lipopolysaccharide Variation in Innate Immune Evasion. Front. Immunol. 2022, 13, 868225. [Google Scholar] [CrossRef] [PubMed]
- Topi, S.; Bottalico, L.; Charitos, I.A.; Colella, M.; Di Domenico, M.; Palmirotta, R.; Santacroce, L. Biomolecular Mechanisms of Autoimmune Diseases and Their Relationship with the Resident Microbiota: Friend or Foe? Pathophysiology 2022, 29, 507–536. [Google Scholar] [CrossRef] [PubMed]
- Varon, C.; Azzi-Martin, L.; Khalid, S.; Seeneevassen, L.; Ménard, A.; Spuul, P. Helicobacters and Cancer, Not Only Gastric Cancer? Semin. Cancer Biol. 2021, 86 Pt 2, 1138–1154. [Google Scholar] [CrossRef] [PubMed]
- Chang, C.C.; Few, L.L.; Konrad, M.; See Too, W.C. Phosphorylation of Human Choline Kinase Beta by Protein Kinase A: Its Impact on Activity and Inhibition. PLoS ONE 2016, 11, e0154702. [Google Scholar] [CrossRef] [PubMed]
- Tabassam, F.H.; Graham, D.Y.; Yamaoka, Y. Helicobacter pylori activate epidermal growth factor receptor- and phosphatidylinositol 3-OH kinase-dependent Akt and glycogen synthase kinase 3beta phosphorylation. Cell Microbiol. 2009, 11, 70–82. [Google Scholar] [CrossRef] [PubMed]
- Shenker, B.J.; Walker, L.P.; Zekavat, A.; Dlakić, M.; Boesze-Battaglia, K. Blockade of the PI-3K signalling pathway by the Aggregatibacter actinomycetemcomitans cytolethal distending toxin induces macrophages to synthesize and secrete pro-inflammatory cytokines. Cell Microbiol. 2014, 16, 1391–1404. [Google Scholar] [CrossRef] [PubMed]
- Losacco, T.; Cagiano, R.; Bottalico, L.; Carlaio, R.G.; Prejbeanu, R.; Vermesan, H.; Dragulescu, S.I.; Vermesan, D.; Motoc, A.; Santacroce, L. Our experience in Helicobacter pylori infection and gastric MALToma. Clin. Ter. 2008, 159, 239–242. [Google Scholar]
- Sharma, M.; Shukla, G. Metabiotics: One Step ahead of Probiotics; an Insight into Mechanisms Involved in Anticancerous Effect in Colorectal Cancer. Front. Microbiol. 2016, 2, 1940. [Google Scholar] [CrossRef]
- Arthur, J.C.; Perez-Chanona, E.; Mühlbauer, M.; Tomkovich, S.; Uronis, J.M.; Fan, T.-J.; Campbell, B.J.; Abujamel, T.; Dogan, B.; Rogers, A.B.; et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012, 338, 120–123. [Google Scholar] [CrossRef] [PubMed]
- Di Domenico, M.; Ballini, A.; Boccellino, M.; Scacco, S.; Lovero, R.; Charitos, I.A.; Santacroce, L. The Intestinal Microbiota May Be a Potential Theranostic Tool for Personalized Medicine. J. Pers. Med. 2022, 12, 523. [Google Scholar] [CrossRef] [PubMed]
- Ferreira, R.M.; Pereira-Marques, J.; Pinto-Ribeiro, I.; Costa, J.L.; Carneiro, F.; Machado, J.C.; Figueiredo, C. Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut 2018, 67, 226–236. [Google Scholar] [CrossRef] [PubMed]
- Boehm, E.T.; Thon, C.; Kupcinskas, J.; Steponaitiene, R.; Skieceviciene, J.; Canbay, A.; Malfertheiner, P.; Link, A. Fusobacterium nucleatum is associated with worse prognosis in Lauren’s diffuse type gastric cancer patients. Sci. Rep. 2020, 10, 16240. [Google Scholar] [CrossRef] [PubMed]
- Nascimento Araujo, C.D.; Amorim, A.T.; Barbosa, M.S.; Alexandre, J.; Campos, G.B.; Macedo, C.L.; Marques, L.M.; Timenetsky, J. Evaluating the presence of mycoplasma hyorhinis, Fusobacterium nucleatum, and Helicobacter pylori in biopsies of patients with gastric cancer. Infect. Agents Cancer 2021, 16, 70. [Google Scholar] [CrossRef] [PubMed]
- Hsieh, Y.-Y.; Tung, S.-Y.; Pan, H.-Y.; Chang, T.-S.; Wei, K.-L.; Chen, W.-M.; Deng, Y.-F.; Lu, C.-K.; Lai, Y.-H.; Wu, C.-S.; et al. Fusobacterium nucleatum colonization is associated with decreased survival of Helicobacter pylori-positive gastric cancer patients. World J. Gastroenterol. 2021, 27, 7311–7323. [Google Scholar] [CrossRef] [PubMed]
- Morales-Sanchez, A.; Fuentes-Panana, E.M. Epstein-Barr Virus-associated Gastric Cancer and Potential Mechanisms of Oncogenesis. Curr. Cancer Drug Targets 2017, 17, 534–554. [Google Scholar] [CrossRef] [PubMed]
- Qiu, M.Z.; He, C.Y.; Lu, S.X.; Guan, W.; Wang, F.; Wang, X.; Jin, Y.; Wang, F.; Li, Y.; Shao, J.; et al. Prospective observation: Clinical utility of plasma Epstein-Barr virus DNA load in EBV-associated gastric carcinoma patients. Int. J. Cancer 2020, 146, 272–280. [Google Scholar] [CrossRef]
- Papon, N.; Hohl, T.M.; Zhai, B. Mycobiota dysbiosis and gastric tumorigenesis. Theranostics 2021, 11, 7488–7490. [Google Scholar] [CrossRef]
- Vivier, E.; Artis, D.; Colonna, M.; Diefenbach, A.; Di Santo, J.P.; Eberl, G.; Koyasu, S.; Locksley, R.M.; McKenzie, A.N.J.; Mebius, R.E.; et al. Innate Lymphoid Cells: 10 Years On. Cell 2018, 174, 1054–1066. [Google Scholar] [CrossRef]
- Melo-Gonzalez, F.; Hepworth, M.R. Functional and phenotypic heterogeneity of group 3 innate lymphoid cells. Immunology 2017, 150, 265–275. [Google Scholar] [CrossRef] [PubMed]
- Jiao, Y.; Zhang, Y.G.; Lin, Z.; Lu, R.; Xia, Y.; Meng, C.; Pan, Z.; Xu, X.; Jiao, X.; Sun, J. Salmonella Enteritidis Effector AvrA Suppresses Autophagy by Reducing Beclin-1 Protein. Front. Immunol. 2020, 11, 686. [Google Scholar] [CrossRef] [PubMed]
- Magrone, T.; Jirillo, E. The interleukin-17/interleukin-22 innate axis in the gut as a new drug target in allergic-inflammatory and autoimmune diseases. A working hypothesis. Endocr. Metab. Immune Disord. Drug Targets 2014, 14, 145–151. [Google Scholar] [CrossRef] [PubMed]
- Klose, C.S.N.; Flach, M.; Möhle, L.; Rogell, L.; Hoyler, T.; Ebert, K.; Fabiunke, C.; Pfeifer, D.; Sexl, V.; Fonseca-Pereira, D.; et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 2014, 157, 340–356. [Google Scholar] [CrossRef] [PubMed]
- Hoyler, T.; Klose, C.S.; Souabni, A.; Turqueti-Neves, A.; Pfeifer, D.; Rawlins, E.L.; Voehringer, D.; Busslinger, M.; Diefenbach, A. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 2012, 37, 634–648. [Google Scholar] [CrossRef] [PubMed]
- Spits, H.; Artis, D.; Colonna, M.; Diefenbach, A.; Di Santo, J.P.; Eberl, G.; Koyasu, S.; Locksley, R.M.; McKenzie, A.N.J.; Mebius, R.E.; et al. Innate lymphoid cells—A proposal for uniform nomenclature. Nat. Rev. Immunol. 2013, 13, 145–149. [Google Scholar] [CrossRef] [PubMed]
- Yun, C.H.; Lundgren, A.; Azem, J.; Sjöling, A.; Holmgren, J.; Svennerholm, A.-M.; Lundin, B.S. Natural killer cells and Helicobacter pylori infection: Bacterial antigens and interleukin-12 act synergistically to induce gamma interferon production. Infect. Immun. 2005, 73, 1482–1490. [Google Scholar] [CrossRef]
- Hafsi, N.; Voland, P.; Schwendy, S.; Rad, R.; Reindl, W.; Gerhard, M.; Prinz, C. Human dendritic cells respond to Helicobacter pylori, promoting NK cell and Th1-effector responses in vitro. J. Immunol. 2004, 173, 1249–1257. [Google Scholar] [CrossRef]
- Rudnicka, K.; Miszczyk, E.; Matusiak, A.; Walencka, M.; Moran, A.P.; Rudnicka, W.; Chmiela, M. Helicobacter pylori-driven modulation of NK cell expansion, intracellular cytokine expression and cytotoxic activity. Innate Immun. 2015, 21, 127–139. [Google Scholar] [CrossRef]
- Gur, C.; Maalouf, N.; Shhadeh, A.; Berhani, O.; Singer, B.B.; Bachrach, G.; Mandelboim, O. Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1. Oncoimmunology 2019, 8, e1581531. [Google Scholar] [CrossRef]
- Gur, C.; Maalouf, N.; Gerhard, M.; Singer, B.B.; Emgård, J.; Temper, V.; Neuman, T.; Mandelboim, O.; Bachrach, G. The Helicobacter pylori HopQ outermembrane protein inhibits immune cell activities. Oncoimmunology 2019, 8, e1553487. [Google Scholar] [CrossRef] [PubMed]
- Charitos, I.A.; D’Agostino, D.; Topi, S.; Bottalico, L. 40 Years of Helicobacter pylori: A Revolution in Biomedical Thought. Gastroenterol. Insights 2021, 12, 111–135. [Google Scholar] [CrossRef]
- Betten, A.; Bylund, J.; Christophe, T.; Boulay, F.; Romero, A.; Hellstrand, K.; Dahlgren, C. A proinflammatory peptide from Helicobacter pylori activates monocytes to induce lymphocyte dysfunction and apoptosis. J. Clin. Investig. 2001, 108, 1221–1228, Erratum in J. Clin. Investig. 2006, 116, 1457. [Google Scholar] [CrossRef] [PubMed]
- Liu, X.; Cao, K.; Xu, C.; Hu, T.; Zhou, L.; Cao, D.; Xiao, J.; Luo, L.; Guo, Y.; Qi, Y. GATA-3 augmentation down-regulates Connexin43 in Helicobacter pylori associated gastric carcinogenesis. Cancer Biol. Ther. 2015, 16, 987–996. [Google Scholar] [CrossRef]
- Buzzelli, J.N.; Chalinor, H.V.; Pavlic, D.I.; Sutton, P.; Menheniott, T.R.; Giraud, A.S.; Judd, L.M. IL33 Is a Stomach Alarmin That Initiates a Skewed Th2 Response to Injury and Infection. Cell Mol. Gastroenterol. Hepatol. 2015, 1, 203–221.e3. [Google Scholar] [CrossRef] [PubMed]
- Satoh-Takayama, N.; Kato, T.; Motomura, Y.; Kageyama, T.; Taguchi-Atarashi, N.; Kinoshita-Daitoku, R.; Kuroda, E.; Di Santo, J.P.; Mimuro, H.; Moro, K.; et al. Bacteria-Induced Group 2 Innate Lymphoid Cells in the Stomach Provide Immune Protection through Induction of IgA. Immunity 2020, 52, 635–649.e4. [Google Scholar] [CrossRef] [PubMed]
- Santacroce, L.; Bufo, P.; Latorre, V.; Losacco, T. Role of mast cells in the physiopathology of gastric lesions caused by Helicobacter pylori. Chir. Ital. 2000, 52, 527–531. [Google Scholar] [PubMed]
- Santacroce, L.; Cagiano, R.; Del Prete, R.; Bottalico, L.; Sabatini, R.; Carlaio, R.G.; Prejbeanu, R.; Vermesan, H.; Dragulescu, S.I.; Vermesan, D.; et al. Helicobacter pylori infection and gastric MALTomas: An up-to-date and therapy highlight. Clin. Ter. 2008, 159, 457–462. [Google Scholar] [PubMed]
- Wu, S.; Xu, Y.; Chen, Z.; Chen, Y.; Wei, F.; Xia, C.; Zhou, Q.; Li, P.; Gu, Q. Lactiplantibacillus plantarum ZJ316 Reduces Helicobacter pylori Adhesion and Inflammation by Inhibiting the Expression of Adhesin and Urease Genes. Mol. Nutr. Food Res. 2023, 67, e2300241. [Google Scholar] [CrossRef]
- Hill, C.; Guarner, F.; Reid, G.; Gibson, G.R.; Merenstein, D.J.; Pot, B.; Morelli, L.; Canani, R.B.; Flint, H.J.; Salminen, S.; et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014, 11, 506–514. [Google Scholar] [CrossRef]
- Sang, L.X.; Chang, B.; Zhang, W.L.; Wu, X.M.; Li, X.H.; Jiang, M. Remission induction and maintenance effect of probiotics on ulcerative colitis: A meta-analysis. World J. Gastroenterol. 2010, 16, 1908–1915. [Google Scholar] [CrossRef] [PubMed]
- Ebrahimpour-Koujan, S.; Milajerdi, A.; Larijani, B.; Esmaillzadeh, A. Effects of probiotics on salivary cytokines and immunoglobulines: A systematic review and meta-analysis on clinical trials. Sci. Rep. 2020, 10, 11800. [Google Scholar] [CrossRef] [PubMed]
- Panpetch, W.; Spinler, J.K.; Versalovic, J.; Tumwasorn, S. Characterization of Lactobacillus salivarius strains B37 and B60 capable of inhibiting IL-8 production in Helicobacter pylori-stimulated gastric epithelial cells. BMC Microbiol. 2016, 16, 242. [Google Scholar] [CrossRef] [PubMed]
- Lin, C.C.; Huang, W.C.; Su, C.H.; Lin, W.-D.; Wu, W.-T.; Yu, B.; Hsu, Y.-M. Effects of Multi-Strain Probiotics on Immune Responses and Metabolic Balance in Helicobacter pylori-Infected Mice. Nutrients 2020, 12, 2476. [Google Scholar] [CrossRef]
- Raheem, A.; Liang, L.; Zhang, G.; Cui, S. Modulatory Effects of Probiotics during Pathogenic Infections with Emphasis on Immune Regulation. Front. Immunol. 2021, 12, 616713. [Google Scholar] [CrossRef] [PubMed]
- Murosaki, S.; Muroyama, K.; Yamamoto, Y.; Yoshikai, Y. Antitumor effect of heat-killed Lactobacillus plantarum L-137 through restoration of impaired interleukin-12 production in tumor-bearing mice. Cancer Immunol. Immunother. 2000, 49, 157–164. [Google Scholar] [CrossRef] [PubMed]
- Keikha, M.; Karbalaei, M. Probiotics as the live microscopic fighters against Helicobacter pylori gastric infections. BMC Gastroenterol. 2021, 21, 388. [Google Scholar] [CrossRef] [PubMed]
- Eslami, M.; Yousefi, B.; Kokhaei, P.; Moghadas, A.J.; Moghadam, B.S.; Arabkari, V.; Niazi, Z. Are probiotics useful for therapy of Helicobacter pylori diseases? Comp. Immunol. Microbiol. Infect. Dis. 2019, 64, 99–108. [Google Scholar] [CrossRef]
- Santacroce, L.; Di Domenico, M.; Montagnani, M.; Jirillo, E. Antibiotic Resistance and Microbiota Response. Curr. Pharm. Des. 2023, 29, 356–364. [Google Scholar] [CrossRef]
- Tursi, A.; Brandimarte, G.; Giorgetti, G.M.; Modeo, M.E. Effect of Lactobacillus casei supplementation on the effectiveness and tolerability of a new second-line 10-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection. Med. Sci. Monit. 2004, 10, CR662–CR666. [Google Scholar]
- Song, H.; Zhou, L.; Liu, D.; Ge, L.; Li, Y. Probiotic effect on Helicobacter pylori attachment and inhibition of inflammation in human gastric epithelial cells. Exp. Ther. Med. 2019, 18, 1551–1562. [Google Scholar] [CrossRef] [PubMed]
- Teame, T.; Wang, A.; Xie, M.; Zhang, Z.; Yang, Y.; Ding, Q.; Gao, C.; Olsen, R.E.; Ran, C.; Zhou, Z. Paraprobiotics and Postbiotics of Probiotic Lactobacilli, Their Positive Effects on the Host and Action Mechanisms: A Review. Front. Nutr. 2020, 7, 570344. [Google Scholar] [CrossRef] [PubMed]
- Sankarapandian, V.; Venmathi Maran, B.A.; Rajendran, R.L.; Jogalekar, M.P.; Gurunagarajan, S.; Krishnamoorthy, R.; Gangadaran, P.; Ahn, B.-C. An Update on the Effectiveness of Probiotics in the Prevention and Treatment of Cancer. Life 2022, 12, 59. [Google Scholar] [CrossRef] [PubMed]
- Gibson, G.R.; Hutkins, R.; Sanders, M.E.; Prescott, S.L.; Reimer, R.A.; Salminen, S.J.; Scott, K.; Stanton, C.; Swanson, K.S.; Cani, P.D.; et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat. Rev. Gastroenterol. Hepatol. 2017, 14, 491–502. [Google Scholar] [CrossRef] [PubMed]
- Serban, D.E. Gastrointestinal cancers: Influence of gut microbiota, probiotics and prebiotics. Cancer Lett. 2014, 345, 258–270. [Google Scholar] [CrossRef] [PubMed]
- Ballan, R.; Battistini, C.; Xavier-Santos, D.; Saad, S.M.I. Interactions of probiotics and prebiotics with the gut microbiota. Prog. Mol. Biol. Transl. Sci. 2020, 171, 265–300. [Google Scholar] [CrossRef] [PubMed]
- Saxena, A.; Mukhopadhyay, A.K.; Nandi, S.P. Helicobacter pylori: Perturbation and restoration of gut microbiome. J. Biosci. 2020, 45, 110. [Google Scholar] [CrossRef] [PubMed]
- Liu, M.; Gao, H.; Miao, J.; Zhang, Z.; Zheng, L.; Li, F.; Zhou, S.; Zhang, Z.; Li, S.; Liu, H.; et al. Helicobacter pylori infection in humans and phytotherapy, probiotics, and emerging therapeutic interventions: A review. Front. Microbiol. 2024, 14, 1330029. [Google Scholar] [CrossRef] [PubMed]
- Magrone, T.; Magrone, M.; Russo, M.A.; Jirillo, E. Taking Advantage of Plant Defense Mechanisms to Promote Human Health. Exploitation of Plant Natural Products for Preventing or Treating Human Disease: Second of Two Parts. Endocr. Metab. Immune Disord. Drug Targets 2021, 21, 1961–1973. [Google Scholar] [CrossRef]
- Durazzo, A.; Lucarini, M.; Souto, E.B.; Cicala, C.; Caiazzo, E.; Izzo, A.A.; Novellino, E.; Santini, A. Polyphenols: A concise overview on the chemistry, occurrence, and human health. Phytother. Res. 2019, 33, 2221–2243. [Google Scholar] [CrossRef]
- Ardalani, H.; Hadipanah, A.; Sahebkar, A. Medicinal Plants in the Treatment of Peptic Ulcer Disease: A Review. Mini Rev. Med. Chem. 2020, 20, 662–702. [Google Scholar] [CrossRef] [PubMed]
- Gonciarz, W.; Piątczak, E.; Chmiela, M. The influence of Salvia cadmica Boiss. extracts on the M1/M2 polarization of macrophages primed with Helicobacter pylori lipopolysaccharide in conjunction with NF-kappa B activation, production of cytokines, phagocytic activity and total DNA methylation. J. Ethnopharmacol. 2023, 310, 116386. [Google Scholar] [CrossRef] [PubMed]
- Ragab, T.I.M.; Shalaby, A.S.G.; Awdan, S.A.E.; El-Bassyouni, G.T.; Salama, B.M.; Helmy, W.A.; Esawy, M.A. Role of levan extracted from bacterial honey isolates in curing peptic ulcer: In vivo. Int. J. Biol. Macromol. 2020, 142, 564–573. [Google Scholar] [CrossRef]
- Gomez-Chang, E.; Uribe-Estanislao, G.V.; Martinez-Martinez, M.; Gálvez-Mariscal, A.; Romero, I. Anti-Helicobacter pylori Potential of Three Edible Plants Known as Quelites in Mexico. J. Med. Food. 2018, 21, 1150–1157. [Google Scholar] [CrossRef] [PubMed]
- Fan, J.; Zhu, J.; Xu, H. Strategies of Helicobacter pylori in evading host innate and adaptive immunity: Insights and prospects for therapeutic targeting. Front. Cell Infect. Microbiol. 2024, 14, 1342913. [Google Scholar] [CrossRef] [PubMed]
- Gonciarz, W.; Krupa, A.; Hinc, K.; Obuchowski, M.; Moran, A.P.; Gajewski, A.; Chmiela, M. The effect of Helicobacter pylori infection and different H. pylori components on the proliferation and apoptosis of gastric epithelial cells and fibroblasts. PLoS ONE 2019, 14, e0220636. [Google Scholar] [CrossRef] [PubMed]
- Yahiro, K.; Shirasaka, D.; Tagashira, M.; Wada, A.; Morinaga, N.; Kuroda, F.; Choi, O.; Inoue, M.; Aoyama, N.; Ikeda, M.; et al. Inhibitory effects of polyphenols on gastric injury by Helicobacter pylori VacA toxin. Helicobacter 2005, 10, 231–239. [Google Scholar] [CrossRef] [PubMed]
- Kim, S.H.; Lee, M.H.; Park, M.; Woo, H.J.; Kim, Y.S.; Tharmalingam, N.; Seo, W.-D.; Kim, J.-B. Regulatory Effects of Black Rice Extract on Helicobacter pylori Infection-Induced Apoptosis. Mol. Nutr. Food Res. 2018, 62, 1700586. [Google Scholar] [CrossRef] [PubMed]
- Mahady, G.B.; Pendland, S.L.; Chadwick, L.R. Resveratrol and red wine extracts inhibit the growth of CagA+ strains of Helicobacter pylori in vitro. Am. J. Gastroenterol. 2003, 98, 1440–1441. [Google Scholar] [CrossRef]
- Ruggiero, P.; Tombola, F.; Rossi, G.; Pancotto, L.; Lauretti, L.; Del Giudice, G.; Zoratti, M. Polyphenols reduce gastritis induced by Helicobacter pylori infection or VacA toxin administration in mice. Antimicrob. Agents Chemother. 2006, 50, 2550–2552. [Google Scholar] [CrossRef]
- Modolo, L.V.; de Souza, A.X.; Horta, L.P.; Araujo, D.P.; de Fátima, Â. An overview on the potential of natural products as ureases inhibitors: A review. J. Adv. Res. 2015, 6, 35–44. [Google Scholar] [CrossRef] [PubMed]
- Jha, A.; Duffield, K.M.; Ness, M.R.; Ravoori, S.; Andrews, G.; Bhullar, K.S.; Rupasinghe, H.V.; Balzarini, J. Curcumin-inspired cytotoxic 3,5-bis(arylmethylene)-1-(N-(ortho-substituted aryl)maleamoyl)-4-piperidones: A novel group of topoisomerase II alpha inhibitors. Bioorg. Med. Chem. 2015, 23, 6404–6417. [Google Scholar] [CrossRef] [PubMed]
- Zheng, R.; Deng, Q.; Liu, Y.; Zhao, P. Curcumin Inhibits Gastric Carcinoma Cell Growth and Induces Apoptosis by Suppressing the Wnt/β-Catenin Signaling Pathway. Med. Sci. Monit. 2017, 23, 163–171. [Google Scholar] [CrossRef] [PubMed]
- Lakshmi, V.; Mishra, V.; Palit, G. A new gastroprotective effect of limonoid compounds xyloccensins x and y from xylocarpus molluccensis in rats. Nat. Prod. Bioprospect. 2014, 4, 277–283. [Google Scholar] [CrossRef] [PubMed]
- Kim, S.; Kim, W.; Kim, D.H.; Jang, J.-H.; Kim, S.-J.; Park, S.-A.; Hahn, H.; Han, B.W.; Na, H.-K.; Chun, K.-S.; et al. Resveratrol suppresses gastric cancer cell proliferation and survival through inhibition of PIM-1 kinase activity. Arch. Biochem. Biophys. 2020, 689, 108413. [Google Scholar] [CrossRef] [PubMed]
- Gao, Q.; Yuan, Y.; Gan, H.Z.; Peng, Q. Resveratrol inhibits the hedgehog signaling pathway and epithelial-mesenchymal transition and suppresses gastric cancer invasion and metastasis. Oncol. Lett. 2015, 9, 2381–2387. [Google Scholar] [CrossRef] [PubMed]
- Santacroce, L.; Topi, S.; Charitos, I.A.; Lovero, R.; Luperto, P.; Palmirotta, R.; Jirillo, E. Current Views about the Inflammatory Damage Triggered by Bacterial Superantigens and Experimental Attempts to Neutralize Superantigen-Mediated Toxic Effects with Natural and Biological Products. Pathophysiology 2024, 31, 18–31. [Google Scholar] [CrossRef] [PubMed]
- Man, A.; Mare, A.; Toma, F.; Curticăpean, A.; Santacroce, L. Health Threats from Contamination of Spices Commercialized in Romania: Risks of Fungal and Bacterial Infections. Endocr. Metab. Immune Disord. Drug Targets 2016, 16, 197–204. [Google Scholar] [CrossRef] [PubMed]
- Yang, T.; Zhang, J.; Zhou, J.; Zhu, M.; Wang, L.; Yan, L. Resveratrol inhibits Interleukin-6 induced invasion of human gastric cancer cells. Biomed. Pharmacother. 2018, 99, 766–773. [Google Scholar] [CrossRef]
- Pagliara, V.; Nasso, R.; Di Donato, P.; Finore, I.; Poli, A.; Masullo, M.; Arcone, R. Lemon Peel Polyphenol Extract Reduces Interleukin-6-Induced Cell Migration, Invasiveness, and Matrix Metalloproteinase-9/2 Expression in Human Gastric Adenocarcinoma MKN-28 and AGS Cell Lines. Biomolecules 2019, 9, 833. [Google Scholar] [CrossRef]
- Da, W.; Zhang, J.; Zhang, R.; Zhu, J. Curcumin inhibits the lymphangiogenesis of gastric cancer cells by inhibiton of HMGB1/VEGF-D signaling. Int. J. Immunopathol. Pharmacol. 2019, 33, 2058738419861600. [Google Scholar] [CrossRef] [PubMed]
- Wu, Y.Y.; Lin, C.W.; Cheng, K.S.; Lin, C.; Wang, Y.M.; Lin, I.T.; Chou, Y.H.; Hsu, P.N. Increased programmed death-ligand-1 expression in human gastric epithelial cells in Helicobacter pylori infection. Clin. Exp. Immunol. 2010, 161, 551–559. [Google Scholar] [CrossRef] [PubMed]
- Schupack, D.A.; Mars, R.A.T.; Voelker, D.H.; Abeykoon, J.P.; Kashyap, P.C. The promise of the gut microbiome as part of individualized treatment strategies. Nat. Rev. Gastroenterol. Hepatol. 2022, 19, 7–25. [Google Scholar] [CrossRef] [PubMed]
- Sivan, A.; Corrales, L.; Hubert, N.; Williams, J.B.; Aquino-Michaels, K.; Earley, Z.M.; Benyamin, F.W.; Lei, Y.M.; Jabri, B.; Alegre, M.-L.; et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 2015, 350, 1084–1089. [Google Scholar] [CrossRef] [PubMed]
- Ye, Z.N.; Xia, H.H.; Zhang, R.; Li, L.; Wu, L.-H.; Liu, X.-J.; Xie, W.-R.; He, X.-X. The Efficacy of Washed Microbiota Transplantation on Helicobacter pylori Eradication: A Pilot Study. Gastroenterol. Res. Pract. 2020, 2020, 8825189. [Google Scholar] [CrossRef] [PubMed]
- Elangovan, A.; Allegretti, J.R.; Fischer, M. Microbiota modulation-based therapy for luminal GI disorders: Current applications of probiotics and fecal microbiota transplantation. Expert Opin. Biol. Ther. 2019, 19, 1343–1355. [Google Scholar] [CrossRef]
- Moss, S.F.; Shah, S.C.; Tan, M.C.; El-Serag, H.B. Evolving Concepts in Helicobacter pylori Management. Gastroenterology 2024, 166, 267–283. [Google Scholar] [CrossRef]
- Yin, X.; Lai, Y.; Du, Y.; Zhang, T.; Gao, J.; Li, Z. Metal-Based Nanoparticles: A Prospective Strategy for Helicobacter pylori Treatment. Int. J. Nanomed. 2023, 18, 2413–2429. [Google Scholar] [CrossRef]
- Serov, D.A.; Khabatova, V.V.; Vodeneev, V.; Li, R.; Gudkov, S.V. A Review of the Antibacterial, Fungicidal and Antiviral Properties of Selenium Nanoparticles. Materials 2023, 16, 5363. [Google Scholar] [CrossRef]
- Fonseca, D.R.; Alves, P.M.; Neto, E.; Custódio, B.; Guimarães, S.; Moura, D.; Annis, F.; Martins, M.; Gomes, A.; Teixeira, C.; et al. One-Pot Microfluidics to Engineer Chitosan Nanoparticles Conjugated with Antimicrobial Peptides Using “Photoclick” Chemistry: Validation Using the Gastric Bacterium Helicobacter pylori. ACS Appl. Mater. Interfaces 2024, 16, 14533–14547. [Google Scholar] [CrossRef]
Mechanisms of Gastric Cancer Development | |
---|---|
H.p.-Mediated |
|
Non-H.p.-Mediated |
|
Major Effects of Probiotics and Prebiotics in H.p. Infection | |
---|---|
Probiotics | Prebiotics |
|
|
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Santacroce, L.; Topi, S.; Bottalico, L.; Charitos, I.A.; Jirillo, E. Current Knowledge about Gastric Microbiota with Special Emphasis on Helicobacter pylori-Related Gastric Conditions. Curr. Issues Mol. Biol. 2024, 46, 4991-5009. https://doi.org/10.3390/cimb46050299
Santacroce L, Topi S, Bottalico L, Charitos IA, Jirillo E. Current Knowledge about Gastric Microbiota with Special Emphasis on Helicobacter pylori-Related Gastric Conditions. Current Issues in Molecular Biology. 2024; 46(5):4991-5009. https://doi.org/10.3390/cimb46050299
Chicago/Turabian StyleSantacroce, Luigi, Skender Topi, Lucrezia Bottalico, Ioannis Alexandros Charitos, and Emilio Jirillo. 2024. "Current Knowledge about Gastric Microbiota with Special Emphasis on Helicobacter pylori-Related Gastric Conditions" Current Issues in Molecular Biology 46, no. 5: 4991-5009. https://doi.org/10.3390/cimb46050299